PriceTargets.com logo

ETR:RHK - RHÖN-KLINIKUM Aktiengesellschaft Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: €0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
€15.70 As of 06/29/2022 01:00 AM ET
+0.30 (1.20%)

This chart shows the closing price for RHK by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New RHÖN-KLINIKUM Aktiengesellschaft Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for RHK and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for RHK

Analyst Price Target is €0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for RHÖN-KLINIKUM Aktiengesellschaft in the last 3 months. The average price target is €0.00, with a high forecast of €0.00 and a low forecast of €0.00. The average price target represents a -100.00% upside from the last price of €15.70.

This chart shows the closing price for RHK for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in RHÖN-KLINIKUM Aktiengesellschaft. This rating has held steady since June 2021, when it changed from a Sell consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 1 sell ratings
Ratings as of
1/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
4/6/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/5/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/1/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
6/8/2020Independent ResearchSet Price TargetSell€18.00
3/27/2020Independent ResearchSet Price TargetNeutral€18.00
3/5/2020Independent ResearchSet Price TargetSell€18.00
3/3/2020Berenberg BankSet Price TargetNeutral€18.00
3/2/2020Kepler Capital MarketsSet Price TargetNeutral€18.00
2/26/2020Independent ResearchSet Price TargetNeutral€17.60
2/24/2020Kepler Capital MarketsSet Price TargetSell€14.30
2/21/2020Berenberg BankSet Price TargetNeutral€19.75
12/2/2019Berenberg BankSet Price TargetNeutral€19.75
11/21/2019Independent ResearchSet Price TargetNeutral€19.80
11/19/2019Credit Suisse GroupSet Price TargetSell€16.50
11/13/2019Credit Suisse GroupSet Price TargetSell€16.50
8/5/2019Independent ResearchSet Price TargetNeutral€25.50
8/5/2019Credit Suisse GroupSet Price TargetSell€16.50
7/30/2019Berenberg BankSet Price TargetNeutral€26.20
5/10/2019Independent ResearchSet Price TargetNeutral€27.00
5/10/2019Credit Suisse GroupSet Price TargetSell€16.50
5/3/2019Warburg ResearchSet Price TargetNeutral€25.50
5/3/2019Berenberg BankSet Price TargetNeutral€26.20
4/11/2019Kepler Capital MarketsSet Price TargetSell€19.00
4/11/2019Warburg ResearchSet Price TargetNeutral€25.50
4/11/2019Berenberg BankSet Price TargetNeutral€23.50
4/1/2019Kepler Capital MarketsSet Price TargetSell€19.00
4/1/2019Independent ResearchSet Price TargetNeutral€26.00
2/26/2019Independent ResearchSet Price TargetNeutral€25.00
2/25/2019Warburg ResearchSet Price TargetNeutral€25.50
2/19/2019Warburg ResearchSet Price TargetNeutral€25.50
1/23/2019Credit Suisse GroupSet Price TargetSell€17.00
1/11/2019Warburg ResearchSet Price TargetNeutral€25.50
1/9/2019Kepler Capital MarketsSet Price TargetSell€19.00
11/16/2018CommerzbankSet Price TargetSell€19.00
11/14/2018Berenberg BankSet Price TargetNeutral€23.50
11/13/2018Independent ResearchSet Price TargetNeutral€24.00
11/12/2018CfraSet Price TargetSell€22.00
11/9/2018CommerzbankSet Price TargetNeutral€25.00
11/9/2018Warburg ResearchSet Price TargetNeutral€25.20
9/17/2018Warburg ResearchSet Price TargetNeutral€25.20
8/8/2018Independent ResearchSet Price TargetNeutral€26.00
8/6/2018Berenberg BankSet Price TargetNeutral€27.75
8/6/2018Credit Suisse GroupSet Price TargetSell€19.00
8/3/2018CfraSet Price TargetSell€25.00
8/2/2018Kepler Capital MarketsSet Price TargetSell€22.00
8/2/2018Warburg ResearchSet Price TargetNeutral€25.20
8/2/2018CommerzbankSet Price TargetNeutral€25.00
5/14/2018Berenberg BankSet Price TargetNeutral€29.15
5/8/2018Independent ResearchSet Price TargetNeutral€29.00
5/4/2018Warburg ResearchSet Price TargetNeutral€25.20
5/4/2018Kepler Capital MarketsSet Price TargetSell€22.00
4/4/2018Warburg ResearchSet Price TargetNeutral€25.20
4/3/2018Independent ResearchSet Price TargetNeutral€29.00
3/29/2018Warburg ResearchSet Price TargetNeutral€25.20
3/20/2018Warburg ResearchSet Price TargetNeutral€25.20
3/8/2018Credit Suisse GroupSet Price TargetSell€23.50
2/27/2018CfraSet Price TargetSell€25.00
2/23/2018Berenberg BankSet Price TargetNeutral€29.15
2/14/2018Warburg ResearchSet Price TargetSell€25.00
1/22/2018Deutsche Bank AktiengesellschaftSet Price TargetNeutral€22.00
12/13/2017DZ BankReiterated RatingSell
12/1/2017Deutsche Bank AktiengesellschaftSet Price TargetNeutral€22.00
11/13/2017Deutsche Bank AktiengesellschaftSet Price TargetNeutral€22.00
11/13/2017Independent ResearchSet Price TargetNeutral€32.00
11/13/2017Warburg ResearchSet Price TargetNeutral€26.30
11/13/2017Berenberg BankSet Price TargetNeutral€29.15
11/10/2017S&P GlobalSet Price TargetSell€25.00
11/10/2017Baader BankSet Price TargetNeutral€24.00
11/10/2017CommerzbankSet Price TargetNeutral€25.00
11/7/2017Warburg ResearchSet Price TargetNeutral€26.30
11/6/2017Berenberg BankSet Price TargetNeutral€29.15
9/20/2017Berenberg BankSet Price TargetNeutral€26.50
9/18/2017CommerzbankSet Price TargetNeutral€25.00
8/29/2017DZ BankReiterated RatingSell
8/14/2017Independent ResearchSet Price TargetNeutral€28.00
8/7/2017Berenberg BankSet Price TargetNeutral€26.50
8/4/2017Deutsche Bank AktiengesellschaftSet Price TargetNeutral€21.00
8/4/2017Credit Suisse GroupSet Price TargetSell€24.40
8/3/2017CommerzbankSet Price TargetNeutral€25.00
8/3/2017Baader BankSet Price TargetNeutral€24.00
8/3/2017Warburg ResearchSet Price TargetNeutral€26.00
8/3/2017Jefferies Financial GroupSet Price TargetSell€17.60
8/1/2017Berenberg BankSet Price TargetNeutral€26.00
7/26/2017Deutsche Bank AktiengesellschaftSet Price TargetNeutral€21.00
7/25/2017CommerzbankSet Price TargetNeutral€25.00
(Data available from 6/30/2017 forward)

News Sentiment Rating

0.00 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/2/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/31/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
3/2/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/1/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/1/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/31/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/30/2022

Current Sentiment

  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

  • No very positive mentions tracked during this time.
RHÖN-KLINIKUM Aktiengesellschaft logo
RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, offers in-patient, semi-patient, and outpatient healthcare services in Germany. Its hospitals offer treatment services, including rehabilitation of cardiovascular patients, hand surgery, neurological, psychosomatic, addiction therapy facilities, ophthalmology, trauma surgery, dentistry, thoracic, pulmonary, vascular, tumors, neurological conditions, and treatment of spinal column, joints, and heart diseases. It operates eight hospitals and 5,420 beds/places at five medical sites. The company is based in Bad Neustadt an der Saale, Germany.
Read More

Today's Range

Now: €15.70
Low: €15.50
High: €15.70

50 Day Range

MA: €15.27
Low: €14.35
High: €16.20

52 Week Range

Now: €15.70
Low: €14.16
High: €16.44

Volume

160 shs

Average Volume

43,281 shs

Market Capitalization

$1.05 billion

P/E Ratio

43.73

Dividend Yield

1.60%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of RHÖN-KLINIKUM Aktiengesellschaft?

The following sell-side analysts have issued research reports on RHÖN-KLINIKUM Aktiengesellschaft in the last twelve months:
View the latest analyst ratings for RHK.

What is the current price target for RHÖN-KLINIKUM Aktiengesellschaft?

0 Wall Street analysts have set twelve-month price targets for RHÖN-KLINIKUM Aktiengesellschaft in the last year.
View the latest price targets for RHK.

What is the current consensus analyst rating for RHÖN-KLINIKUM Aktiengesellschaft?

RHÖN-KLINIKUM Aktiengesellschaft currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for RHK.

How do I contact RHÖN-KLINIKUM Aktiengesellschaft's investor relations team?

RHÖN-KLINIKUM Aktiengesellschaft's physical mailing address is Schlossplatz 1, BAD NEUSTADT AN DER SAALE, 97616, Germany. The company's listed phone number is +49-9-771650. The official website for RHÖN-KLINIKUM Aktiengesellschaft is www.rhoen-klinikum-ag.com. Learn More about contacing RHÖN-KLINIKUM Aktiengesellschaft investor relations.